Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198381010> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W3198381010 endingPage "426" @default.
- W3198381010 startingPage "421" @default.
- W3198381010 abstract "Interferon alfacon-1 (Advaferon, also referred to as consensus interferon) is a novel synthetic recombinant type-I interferon (IFN) developed by comparing the amino acid sequences of several natural IFN-alpha subtypes and assigning the most frequently observed amino acid in each corresponding position to generate a consensus molecule. Interferon alfacon-1 binds with high affinity to type-I IFN receptors and has greater biological activity than naturally occurring IFN-alpha as assessed by its increased antiviral, anti-proliferative, and natural killer cell activities, as well as its stronger IFN-stimulated gene induction. In a multicenter, randomized, controlled study, the safety and efficacy of interferon alfacon-1 in comparison with lymphoblastoid interferon-alpha [IFN-alpha (NAMALWA)] was evaluated in patients infected with high-titer chronic hepatitis C virus (HCV). Interferon alfacon-1 (18 MIU) was superior in efficacy without additional toxicity to IFN-alpha (NAMALWA) (9 MIU) in high-titer chronic HCV patients, particularly those infected with genotype 1b. A multicenter open-label study showed that treatment with interferon alfacon-1 (12 MIU) was an effective and tolerable therapy in chronic HCV patients with low viral titers. Another multicenter open-label study showed that re-treatment with interferon alfacon-1 (18 MIU) was an effective and tolerable therapy in chronic HCV patients who relapsed after traditional IFN therapy. Collectively, these clinical studies indicate that interferon alfacon-1, as a novel synthetic interferon, may be a useful therapeutic alternative for the effective treatment of hepatitis C." @default.
- W3198381010 created "2021-09-13" @default.
- W3198381010 creator A5061810308 @default.
- W3198381010 creator A5079725460 @default.
- W3198381010 date "2002-01-01" @default.
- W3198381010 modified "2023-10-17" @default.
- W3198381010 title "Interferon alfacon-1 (Advaferon): a novel synthetic interferon for the treatment of hepatitis C, its pharmacological and clinical profile." @default.
- W3198381010 cites W1895101807 @default.
- W3198381010 cites W1993998946 @default.
- W3198381010 cites W1996155796 @default.
- W3198381010 cites W2002746052 @default.
- W3198381010 cites W2007434359 @default.
- W3198381010 cites W2043063112 @default.
- W3198381010 cites W2043886637 @default.
- W3198381010 cites W2081890213 @default.
- W3198381010 cites W2164674340 @default.
- W3198381010 cites W2315201676 @default.
- W3198381010 cites W2011949877 @default.
- W3198381010 doi "https://doi.org/10.1254/fpj.120.421" @default.
- W3198381010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12528473" @default.
- W3198381010 hasPublicationYear "2002" @default.
- W3198381010 type Work @default.
- W3198381010 sameAs 3198381010 @default.
- W3198381010 citedByCount "5" @default.
- W3198381010 countsByYear W31983810102012 @default.
- W3198381010 crossrefType "journal-article" @default.
- W3198381010 hasAuthorship W3198381010A5061810308 @default.
- W3198381010 hasAuthorship W3198381010A5079725460 @default.
- W3198381010 hasBestOaLocation W31983810101 @default.
- W3198381010 hasConcept C159047783 @default.
- W3198381010 hasConcept C203014093 @default.
- W3198381010 hasConcept C2522874641 @default.
- W3198381010 hasConcept C2776178377 @default.
- W3198381010 hasConcept C2776408679 @default.
- W3198381010 hasConcept C2776455275 @default.
- W3198381010 hasConcept C2781228144 @default.
- W3198381010 hasConcept C2909179924 @default.
- W3198381010 hasConcept C32611913 @default.
- W3198381010 hasConcept C71924100 @default.
- W3198381010 hasConceptScore W3198381010C159047783 @default.
- W3198381010 hasConceptScore W3198381010C203014093 @default.
- W3198381010 hasConceptScore W3198381010C2522874641 @default.
- W3198381010 hasConceptScore W3198381010C2776178377 @default.
- W3198381010 hasConceptScore W3198381010C2776408679 @default.
- W3198381010 hasConceptScore W3198381010C2776455275 @default.
- W3198381010 hasConceptScore W3198381010C2781228144 @default.
- W3198381010 hasConceptScore W3198381010C2909179924 @default.
- W3198381010 hasConceptScore W3198381010C32611913 @default.
- W3198381010 hasConceptScore W3198381010C71924100 @default.
- W3198381010 hasIssue "6" @default.
- W3198381010 hasLocation W31983810101 @default.
- W3198381010 hasLocation W31983810102 @default.
- W3198381010 hasOpenAccess W3198381010 @default.
- W3198381010 hasPrimaryLocation W31983810101 @default.
- W3198381010 hasRelatedWork W2004314479 @default.
- W3198381010 hasRelatedWork W2010577532 @default.
- W3198381010 hasRelatedWork W2050318447 @default.
- W3198381010 hasRelatedWork W2062901722 @default.
- W3198381010 hasRelatedWork W2070480238 @default.
- W3198381010 hasRelatedWork W2083211870 @default.
- W3198381010 hasRelatedWork W2229086442 @default.
- W3198381010 hasRelatedWork W2414025728 @default.
- W3198381010 hasRelatedWork W2418652184 @default.
- W3198381010 hasRelatedWork W3148119108 @default.
- W3198381010 hasVolume "120" @default.
- W3198381010 isParatext "false" @default.
- W3198381010 isRetracted "false" @default.
- W3198381010 magId "3198381010" @default.
- W3198381010 workType "article" @default.